After participating in a panel session discussing the exciting developments in neuromodulation therapies, Denis Pasero, product commercialisation manager, from Ilika sat down with Ian Bolland to discuss the design challenges for battery manufacturers when it comes to small, implantable devices.
Ilika believes that one of the main challenges of powering miniature implants in the sector is to make sure they’re properly powered while not compromising on design and power potential. Then there’s the issue of the end user, are they going to be prepared to recharge the batteries?
Pasero explains: “You can’t expect any technology to have the same power when the battery is a few millimetres long, it needs a conversation with the patient. Is the patient going to be happy with charging the device by themselves? Perhaps every day? That’s not a given. People will be worried that they’ll miss a day. What’s going to happen to that implant? That’s a risk the designers are taking with good signs that this could be accepted at some point because what you have then is a much smaller device, a less risky operation, a device that you won’t even notice.”
Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.
